High MRE11 expression has been implicated with poor prognosis and chemoresistance in gastric cancer, colon cancer, breast cancer as well as glioma (Altan et al., 2016; Bian et al., 2019; Maksoud, 2022). The gene discussed is MRE11; the disease is glioma.